CAMBRIDGE, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that the company will participate in the 14th Annual BIO CEO & Investor Conference in New York City. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Tuesday, February 14, 2012 at 9:30 a.m. ET.
